secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0000950170-22-011839
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mednax to rename to Pediatrix Medical Group effective July 1, 2022
------------------------------------------------------------------

- Corporate name changes from Mednax, Inc. to Pediatrix Medical Group, Inc. after market close on July 1, 2022.
- Common stock will continue to trade on NYSE under ticker symbol "MD" unchanged.
- No shareholder action required; existing stock certificates remain valid post-name change.
- CEO Mark Ordan says name change underscores focus on women, babies, and children care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022011839/0000950170-22-011839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022011839/md-20220621.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer